Navigating government funding, research tax credits, and grant opportunities can often feel complex and overwhelming for growing companies. Between scientific research and experimental development (SR&ED) claims and discretionary incentives, knowing where to start and how to maximize your return is critical to extending your runway. Join incentive experts from Deloitte for an interactive lunch-and-learn session designed to explain the SR&ED and grant landscape. Discover practical strategies to access non-dilutive government funding, reduce overall project costs, and accelerate the growth of your business. What you’ll learn Access government funding: Understand how to navigate the Canadian funding landscape, including tax credits and discretionary incentives. Optimize SR&ED claims: Learn best practices to identify eligible R&D activities and maximize your returns. Reduce project costs: Identify funding streams that lower financial risk and support capital investments, market expansion, and talent development. Leverage the full incentive lifecycle: Gain insights into managing incentives effectively from application through to execution. Securing capital without giving up equity is essential for scaling startups and growing businesses. By understanding how to properly access government tax credits and grants, founders can reinvest key savings directly back into research, talent, and expansion. This workshop connects entrepreneurs with leading industry experts to ensure local businesses leverage every available resource within the innovation ecosystem. Who should attend This session is tailored for leaders looking to optimize their business growth strategies, including: Startup founders and business leaders seeking non-dilutive funding. Chief Financial Officers (CFOs) and financial controllers. Innovative SMEs across technology, life sciences, manufacturing, clean energy, and agriculture. Meet the speakers Mark McQueen, Director at Deloitte’s Global Investment & Innovation Incentives (Gi³) Practice Mark McQueen brings 20 years of expertise in the SR&ED program, leading the life sciences and health care practice for Deloitte Gi³ in Burlington. He works closely with pharmaceutical, therapeutics, and medical device companies, as well as incorporated physicians, to maximize tax credit claims for research and development. Andrew Skeldon, Director at Deloitte’s Global Investment and Innovation Incentives (Gi³) Practice Andrew Skeldon is a Professional Engineer with over 20 years of experience assisting clients across the entire incentives lifecycle. His expertise spans small and medium-sized enterprises to multinational corporations in manufacturing, automotive, clean energy, agriculture, IT, and engineering, helping businesses secure funding for R&D, environmental initiatives, and talent expansion.